2022 annual financial data
Corbus Pharmaceuticals Holdings 2022 Operating cash flow margin
Direct answer
Operating cash flow margin was Not calculable.
Operating income was -34,835,445 USD and net income was -55,833,193 USD.
Operating cash flow was -37,544,435 USD.
Get free Corbus Pharmaceuticals Holdings email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -34,835,445 USD
- Net income
- -55,833,193 USD
- Operating cash flow
- -37,544,435 USD